新辅助免疫疗法的事实和希望:目前的批准和新兴证据
Poorva Vaidya1, Ezra E W Cohen1
1Department of Internal Medicine, Division of Hematology-Oncology, Moores Cancer Center, University of California, San Diego, La Jolla, California.
概括
使用免疫检查点抑制剂的新辅助免疫疗法越来越多地用于早期癌症,如三阴性乳腺癌和非小细胞肺癌. 这种方法在外科手术之外提供了新的治疗选择,预计将有更多的批准.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 癌症治疗方法 癌症治疗方法
背景情况:
- 最近的FDA在2021-2022年的批准突出显示了新辅助剂环境中的免疫检查点抑制剂,用于早期三阴性乳腺癌 (TNBC) 和非小细胞肺癌 (NSCLC) 的治疗.
- 新兴研究表明,在胃肠道,头部和皮肤癌症的手术前,新辅助免疫治疗的好处和挑战.
- 癌症治疗的格局正在转向将新辅助免疫策略纳入早期疾病的治疗.
研究的目的:
- 审查目前支持在新辅助环境中使用免疫检查点抑制剂的证据.
- 讨论正在进行的临床试验,调查早期癌症的新辅助免疫治疗方法.
- 概述多学科癌症护理团队对新辅助免疫疗法与前期手术的关键临床考虑.
主要方法:
- 关于FDA最近批准的文献综述和关于新辅助免疫疗法的发表研究.
- 在各种癌症类型中进行的II期和III期临床试验的总结.
- 对新辅助治疗与立即手术干预的临床决策因素的分析.
主要成果:
- 免疫检查点抑制剂在TNBC和NSCLC的新辅助治疗中获得了吸引力.
- 证据表明有效性,并确定应用新辅助免疫疗法对不同类型癌症的挑战.
- 许多试验正在进行中,这表明这种治疗方式的作用越来越大.
结论:
- 新辅助免疫疗法代表了癌症护理的重大进化,为早期疾病提供了新的范式.
- 预期的批准将扩大免疫检查点抑制剂在新辅助剂环境中的适用范围.
- 仔细考虑证据,正在进行的研究和多学科投入对于最佳的患者管理至关重要.
更多相关视频
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
12.2K
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
11.5K
相关概念视频
01:27Tumor Immunotherapy
533
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
533
01:30Cancer Vaccines
380
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
380
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K